NEW YORK, June 11, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Treace Medical Concepts, Inc. (NASDAQ: TMCI) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Treace Medical caused the company to misrepresent or fail to disclose (1) competition impacted the demand for and utilization of its primary product, the Lapiplasty 3D Bunion Correction System; (2) as a result, T ...

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc." or the "Company") (NASDAQ: TMCI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Treace Medical Concepts, Inc. investors who were adversely affected by alleged securities fraud between May 8, 2023 and May 7, 2024. Follow the link below to get more information and be contacted by a member of our team: ht ...

诉讼案件概述 - 针对Treace Medical Concepts Inc(TMCI)的集体诉讼案件已提起 涉及2023年5月8日至2024年5月7日期间涉嫌证券欺诈 [1] - 诉讼旨在为受不利影响的投资者挽回损失 [1] 指控内容 - 公司被指控作出虚假陈述和/或隐瞒以下事实：竞争影响了其主打产品3D拇趾外翻矫正系统"Lapiplasty"的需求和使用 [2] - 由于竞争导致收入下降 公司需要加速推出替代截骨术的产品 [2] - 公司关于业务、运营和前景的积极陈述存在重大误导性且缺乏合理依据 [2] 诉讼时间节点 - 投资者需在2025年6月10日前申请成为首席原告 [3] - 参与集体诉讼无需支付任何自付费用 [3] 律所背景 - Levi & Korsinsky律所在过去20年中为受损股东追回数亿美元赔偿 [4] - 拥有70多名员工的团队 连续七年入选ISS证券集体诉讼服务Top 50报告 [4]

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI). Shareholders who purchased shares of TMCI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/treace-medical-concepts-inc-loss-submission-form-2/?id=151932&from=3 ...

LOS ANGELES, June 9, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ: TMCI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between May 8, 2023 and May 7, 2024, inclusive (the "Class Period"), ...

集体诉讼案件 - 罗森律师事务所提醒在2023年5月8日至2024年5月7日期间购买Treace Medical Concepts Inc证券的投资者注意2025年6月10日的首席原告截止日期 [1] - 投资者可能有权通过应急费用安排获得补偿而无需支付任何自付费用 [2] - 首席原告是代表其他集体成员指导诉讼的代表方 必须在2025年6月10日前向法院提出申请 [3] 律师事务所背景 - 罗森律师事务所专注于证券集体诉讼和股东衍生诉讼 在全球范围内代表投资者 [4] - 该律所曾创下针对中国公司的最大证券集体诉讼和解记录 [4] - 2017年被ISS证券集体诉讼服务评为和解数量第一 2013年以来每年排名前四 [4] - 2019年为投资者追回超过4.38亿美元 2020年创始合伙人Laurence Rosen被law360评为原告律师界泰斗 [4] 案件详情 - 指控被告在集体诉讼期间做出虚假和/或误导性陈述 未能披露竞争影响了其主打产品Lapiplasty 3D拇趾外翻矫正系统的需求和利用率 [5] - 导致公司收入下降 需要加速推出替代截骨术的产品计划 [5] - 被告对公司业务、运营和前景的积极陈述存在重大误导性且缺乏合理依据 [5] 参与方式 - 投资者可通过指定网址、电话或邮箱联系Phillip Kim律师参与集体诉讼 [3][6] - 在集体认证前 投资者可选择自行聘请律师或保持缺席集体成员身份 [7]

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Treace Medical To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Treace Medical between May 8, 2023, and May 7, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- ...

NEW YORK, June 6, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc." or the "Company") (NASDAQ: TMCI) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Treace Medical Concepts, Inc. investors who were adversely affected by alleged securities fraud between May 8, 2023 and May 7, 2024. Follow the link below to get more information and be contacted by a member of our team:https://z ...

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ: TMCI) between May 8, 2023 and May 7, 2024, both dates inclusive (the “Class Period”), of the important June 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Treace Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arran ...

PONTE VEDRA, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® procedures, today announced that it filed a lawsuit against Zimmer Biomet Holdings, Inc. and Paragon 28, Inc. (collectively, “Zimmer”) (NYSE: ZBH), alleging infringement of 4 patents related to Treace’s in ...